Literature DB >> 7906975

Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report.

K Kasagi1, A Hidaka, K Endo, S Miyamoto, R Takeuchi, T Misaki, H Sakahara, J Konishi.   

Abstract

A 41-year-old hyperthyroid woman visited the hospital in April 1989. She spontaneously developed hypothyroidism in August 1989 and recurrent hyperthyroidism in November 1991. TSH binding inhibitor immunoglobulins (TBII) and thyroid-stimulating antibodies (TSAb) activities were 34.7% (normal range, < 11.0%) and 295.0% (normal range, < 145.0%), respectively, at her first visit. When she was hypothyroid, TBII were 85.9-90.0%, TSAb were 75-190%, and thyroid stimulation-blocking antibodies (TSBAb) activities were 80.0-96.6% (normal range, < 32.2%). When she became hyperthyroid again, TSAb activities were markedly increased to 1108% with TBII and TSBAb activities being 82.2 and 62.8%, respectively. The results indicate that both stimulating and blocking types of TSH receptor antibodies were present in her serum and that her fluctuating thyroid function could be explained by alterations in the balance between the activities of these two types of antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906975     DOI: 10.1089/thy.1993.3.315

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

Review 1.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

2.  The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases.

Authors:  M Rotondi; C Virili; S Pinto; F Coperchini; L Croce; N Brusca; M Centanni; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-08-12       Impact factor: 4.256

3.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.

Authors:  M Braga-Basaria; S Basaria
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

5.  Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.

Authors:  Nobuyuki Takasu; Mina Matsushita
Journal:  J Thyroid Res       Date:  2012-05-10

6.  Alternating hyperthyroidism and hypothyroidism in Graves' disease.

Authors:  Mimi Wong; Warrick J Inder
Journal:  Clin Case Rep       Date:  2018-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.